» Authors » Masanori Tsujimoto

Masanori Tsujimoto

Explore the profile of Masanori Tsujimoto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 83
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Tokuda H, Kuroyanagi G, Tsujimoto M, Matsushima-Nishiwaki R, Akamatsu S, Enomoto Y, et al.
Int J Mol Sci . 2016 May; 17(5). PMID: 27187380
It is generally known that heat shock protein 27 (HSP27) is phosphorylated through p38 mitogen-activated protein (MAP) kinase. We have previously reported that HSP27 is released from human platelets associated...
12.
Tsujimoto M, Kuroyanagi G, Matsushima-Nishiwaki R, Kito Y, Enomoto Y, Iida H, et al.
PLoS One . 2016 Feb; 11(2):e0149077. PMID: 26867010
Selective inhibitors of factor Xa (FXa) are widely recognized as useful therapeutic tools for stroke prevention in non-valvular atrial fibrillation or venous thrombosis. Thrombin, which is rapidly generated from pro-thrombin...
13.
Takagi T, Imai T, Mishiro K, Ishisaka M, Tsujimoto M, Ito H, et al.
J Cereb Blood Flow Metab . 2015 Dec; 37(1):123-139. PMID: 26661252
Intracranial hemorrhage remains a devastating disease. Among antiplatelet drugs, cilostazol, a phosphodiesterase 3 inhibitor, was recently reported to prevent secondary hemorrhagic stroke in patients in a clinical trial. The aim...
14.
Enomoto Y, Takagi T, Matsubara H, Tsujimoto M, Yamauchi K, Yoshimura S, et al.
J Vasc Interv Radiol . 2015 Oct; 26(12):1814-9. PMID: 26428879
Purpose: To evaluate delayed stenosis of the vessels after endovascular thrombectomy using magnetic resonance (MR) angiography. Materials And Methods: Of 82 consecutive patients who underwent successful endovascular treatment for acute...
15.
Tokuda H, Kuroyanagi G, Tsujimoto M, Enomoto Y, Matsushima-Nishiwaki R, Onuma T, et al.
PLoS One . 2015 Jun; 10(6):e0128977. PMID: 26046355
We investigated the relationship between HSP27 phosphorylation and collagen-stimulated activation of platelets in patients with diabetes mellitus (DM). Platelet-rich plasma was prepared from blood of type 2 DM patients. The...
16.
Tsujimoto M, Doi T, Kuroyanagi G, Yamamoto N, Matsushima-Nishiwaki R, Iida Y, et al.
Mol Med Rep . 2015 Mar; 12(1):357-62. PMID: 25760062
Our group has previously shown that αB-crystallin (HSPB5), a small heat shock protein, inhibits human platelet aggregation by ristocetin, an activator of glycoprotein Ib/IX/V. In addition, it was demonstrated that...
17.
Tsujimoto M, Yoshimura S, Enomoto Y, Yamada N, Matsumaru N, Kumada K, et al.
Neurol Med Chir (Tokyo) . 2015 Mar; 55(3):248-52. PMID: 25739430
The present report describes our experience with air transfer of patients with acute ischemic stroke in whom intravenous tissue plasminogen activator (IV t-PA) failed for rescue endovascular therapy (EVT). Twenty-three...
18.
Iida Y, Doi T, Tokuda H, Matsushima-Nishiwaki R, Tsujimoto M, Kuroyanagi G, et al.
Prostaglandins Leukot Essent Fatty Acids . 2014 Dec; 94:73-81. PMID: 25500336
We have previously demonstrated that ristocetin, an activator of GPIb/IX/V, induces the release of soluble CD40 ligand (sCD40L) via thromboxane A2 production in human platelets. It has been shown that...
19.
Enomoto Y, Yoshimura S, Egashira Y, Takagi T, Tsujimoto M, Iwama T
J Stroke Cerebrovasc Dis . 2014 Dec; 23(10):2834-2839. PMID: 25440365
Background: Mechanical thrombectomy is an effective revascularization therapy for acute intracranial large vessel occlusion. We retrospectively evaluated magnetic resonance angiography (MRA) follow-up data to assess the long-term patency of recanalized...
20.
Kaku Y, Funatsu N, Tsujimoto M, Yamashita K, Kokuzawa J
Acta Neurochir Suppl . 2014 Apr; 119:79-82. PMID: 24728638
Background And Aims: Superficial temporal artery (STA) is the mainstay of donor vessels for extra-intracranial bypass (EC-IC bypass) in cerebral revascularization. However, the typically used STA frontal or parietal branch...